- Home
- EQS vs MIRA Comparison
EQS vs MIRA Comparison
Compare EQS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQS
- MIRA
- Stock Information
- Founded
- EQS 1991
- MIRA 2020
- Country
- EQS United States
- MIRA United States
- Employees
- EQS N/A
- MIRA N/A
- Industry
- EQS Finance Companies
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- EQS Finance
- MIRA Health Care
- Exchange
- EQS Nasdaq
- MIRA Nasdaq
- Market Cap
- EQS 18.5M
- MIRA 17.1M
- IPO Year
- EQS N/A
- MIRA 2023
- Fundamental
- Price
- EQS $1.18
- MIRA $1.29
- Analyst Decision
- EQS
- MIRA Strong Buy
- Analyst Count
- EQS 0
- MIRA 2
- Target Price
- EQS N/A
- MIRA $14.00
- AVG Volume (30 Days)
- EQS 3.4K
- MIRA 3.5M
- Earning Date
- EQS 01-01-0001
- MIRA 11-12-2024
- Dividend Yield
- EQS N/A
- MIRA N/A
- EPS Growth
- EQS N/A
- MIRA N/A
- EPS
- EQS N/A
- MIRA N/A
- Revenue
- EQS $1,137,000.00
- MIRA N/A
- Revenue This Year
- EQS N/A
- MIRA N/A
- Revenue Next Year
- EQS N/A
- MIRA N/A
- P/E Ratio
- EQS N/A
- MIRA N/A
- Revenue Growth
- EQS 1795.00
- MIRA N/A
- 52 Week Low
- EQS $1.17
- MIRA $0.51
- 52 Week High
- EQS $1.95
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- EQS 37.54
- MIRA 40.18
- Support Level
- EQS $1.17
- MIRA $1.13
- Resistance Level
- EQS $1.25
- MIRA $1.58
- Average True Range (ATR)
- EQS 0.05
- MIRA 0.19
- MACD
- EQS -0.01
- MIRA -0.06
- Stochastic Oscillator
- EQS 4.00
- MIRA 12.04
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.